003461nam a2200373zi 45000010014000000030008000140050017000220070003000390080041000420200037000830200034001200400031001540720016001850720015002010720015002162450083002312640054003142640079003683360021004473370025004683380023004933650110005163660044006264900024006705000026006945050638007205200943013585450619023016500034029206500033029546500033029877000032030207000035030529781849841429UK-WkNB20210209000000.0ta210209e202201uuxxk | |||||||0|0 eng|d a9781849841429 (pbk.) :cEUR60.00 a184984142X (pbk.) :cEUR60.00 aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aEosinophilic Lung Diseases /cEdited by David J. Jackson, Michael E. Wechsler. 1aSheffield :bEuropean Respiratory Society,c2022. 2aGB :bEuropean Respiratory Society,c[date of distribution not identified] atext2rdacontent aunmediated2rdamedia avolume2rdacarrier a02b60.00cEURd00eThis price includes a tax elementhZ 60.00 0.00 60.00 0.00jGBkxxkmTEDITOR2onix-pt b20220101cIP 20220125jGBkxxk2UK-WkNB0 aERS Monograph ;v95 aPaperback / softback.0 aAn introduction to eosinophils and their biology-- Differential diagnosis of pulmonary eosinophilia-- Biomarkers of eosinophilic inflammation-- Imaging-- Eosinophilic asthma-- Eosinophilic COPD-- Allergic fungal diseases in the upper and lower airways-- Eosinophilic pneumonias-- Hypereosinophilic syndromes and lung involvement-- Eosinophilic granulomatosis with polyangiitis-- Eosinophils and airway nerves in asthma-- Respiratory viruses and eosinophilic airway inflammation-- Eosinophils as potential mediators of autoimmunity-- Safety of eosinophil depletion-- Future prospects of translational and clinical eosinophil research. aThis Monograph will ensure the practicing clinician is better equipped to recognise and treat patients with eosinophilia, as well as appreciate the advances coming in the near future.bA great deal of knowledge about eosinophilic lung diseases has been gained in the last few years, but unanswered questions concerning eosinophil biology still remain. It is in this context that this Monograph was developed. Broad in scope, the book bases its approach to the management of eosinophilic lung diseases on a fundamental understanding of eosinophil biology in health and disease. State-of-the-art reviews written by world-leading authorities and up-and-coming stars in the field take the reader on a journey through the different eosinophilic lung diseases. This Monograph will ensure the practicing clinician is better equipped to recognise and treat patients with eosinophilia, as well as appreciate the advances coming in the near future.0 aDavid J. Jackson is an Associate Professor of Respiratory Medicine at King's College London (London, UK) and Clinical Director of Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust (London, UK), a regional unit for severe asthma, eosinophilic granulomatosis with polyangiitis and other eosinophilic lung diseases. Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH) in Denver (CO, USA), Director of the NJH/Cohen Family Asthma Institute (Denver) and Associate Vice President for Innovation and Industry Relations at NJH. 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aJackson, David J.,eeditor.1 aWechsler, Michael E.,eeditor.